False-positive newborn screen using the beutler spot assay for galactosemia in glucose-6-phosphate dehydrogenase deficiency

Grace Stuhrman, Stefanie J. Perez Juanazo, Kea Crivelly, Jennifer Smith, Hans Andersson, Eva Morava

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Scopus citations

Abstract

Classical galactosemia is detected through newborn screening by measuring galactose-1-phosphate uridylyltransferase (GALT) in the USA primarily via the Beutler spot assay. We report on an 18-month-old patient with glucose-6-phosphate dehydrogenase (G6PD) deficiency that was originally diagnosed with classical galactosemia. The patient presented with elevated liver function enzymes and bilirubinemia and was immediately treated with soy-based formula. Confirmatory tests revealed deficiency of the GALT enzyme, however, full-sequencing of GALT was normal, suggestive of a different ideology. The Beutler spot assay uses three other enzymatic steps in addition to GALT. A deficiency in either of these enzymes can result in suspected decreased GALT activity when using the Beutler assay. Congenital Disorders of Glycosylation screening for phosphoglucomutase-1 deficiency was negative. Quantitative analysis of G6PD enzyme in red blood cells showed a severe deficiency and a deletion in G6PD. Soy-formula, the standard treatment for galactosemia, has been reported to trigger hemolysis in G6PD deficient patients. G6PD and phosphoglucomutase-1 deficiencies should be considered when confirmatory tests are negative for pathogenic variants in GALT and galactose-1-phosphate level is normal.

Original languageEnglish (US)
Title of host publicationJIMD Reports
PublisherSpringer
Pages1-5
Number of pages5
DOIs
StatePublished - 2017

Publication series

NameJIMD Reports
Volume36
ISSN (Print)2192-8304
ISSN (Electronic)2192-8312

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Biochemistry, Genetics and Molecular Biology (miscellaneous)

Fingerprint Dive into the research topics of 'False-positive newborn screen using the beutler spot assay for galactosemia in glucose-6-phosphate dehydrogenase deficiency'. Together they form a unique fingerprint.

  • Cite this

    Stuhrman, G., Perez Juanazo, S. J., Crivelly, K., Smith, J., Andersson, H., & Morava, E. (2017). False-positive newborn screen using the beutler spot assay for galactosemia in glucose-6-phosphate dehydrogenase deficiency. In JIMD Reports (pp. 1-5). (JIMD Reports; Vol. 36). Springer. https://doi.org/10.1007/8904_2016_34